CMS details program to use outcomes-based agreements to pay for sickle cell gene therapies - Endpoints News
endpts.comSubmitted by endpointsnews6292 in health
US Medicaid programs will test a payment model that will reimburse multimillion-dollar gene therapies based on patient outcomes, in an early step toward efforts to finance high-science, high-cost treatments. Starting next year, the Centers for Medicare and Me…